Eosinophils and interleukin-5: the debate continues

Am J Respir Crit Care Med. 2003 Jun 15;167(12):1586-7. doi: 10.1164/rccm.2304001.
No abstract available

Publication types

  • Editorial
  • Review
  • Comment

MeSH terms

  • Anti-Asthmatic Agents / immunology
  • Anti-Asthmatic Agents / therapeutic use*
  • Antibodies, Monoclonal / immunology
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Asthma / complications
  • Asthma / drug therapy*
  • Asthma / immunology
  • Clinical Trials, Phase II as Topic
  • Eosinophilia / blood
  • Eosinophilia / etiology
  • Eosinophils / drug effects*
  • Eosinophils / immunology
  • Forced Expiratory Volume / drug effects
  • Humans
  • Interleukin-5 / antagonists & inhibitors*
  • Interleukin-5 / immunology

Substances

  • Anti-Asthmatic Agents
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Interleukin-5
  • mepolizumab